Advertisement
PSA vs SMA
Which Stock Would AI Choose? Public Storage (PSA) vs. Symmetry Medical (SMA) Stock Comparison
Key Takeaways
- PSA is a large-cap self-storage REIT (real estate investment trust) with an investment-grade balance sheet, while SMA is a small-cap medical device maker—a fundamentally different risk and growth profile.
- Public Storage has pursued aggressive scale via acquisitions, including a roughly $10.5 billion merger with National Storage Affiliates and a $1.2 billion Canadian platform purchase, and has raised its full-year guidance.
- Symmetry Medical operates in surgical instruments, orthopedic implants, and sterilization products, offering higher operating margins but far thinner liquidity and trading depth.
- PSA offers income-oriented investors a substantial dividend and stable cash flows, whereas SMA carries a comparatively higher dividend yield on a much smaller, more volatile equity base.
- Recent momentum favors PSA, which has outperformed its peer group over the trailing three months, while SMA has traded within a relatively tight range near its 52-week highs.
- For more on the latest developments, explore PSA Major News and PSA Today's Price Move, as well as SMA Major News and SMA Today's Price Move.
- To see how automated strategies are positioning across thousands of tickers, explore Trending AI Robots.
Introduction
Public Storage and Symmetry Medical sit at opposite ends of the market spectrum, making their side-by-side evaluation a useful exercise in contrasting investment styles. PSA is a blue-chip self-storage REIT with a market capitalization in the tens of billions, prized for its recurring rental income and dividends. SMA is a small-cap medical device supplier whose fortunes are tied to elective-surgery volumes and hospital capital spending. Investors weighing defensive income generation against higher-beta, specialized growth may find this comparison instructive. Both stocks also carry dividend characteristics, yet their market positioning, volatility, and catalysts differ sharply. This article examines their recent performance, business models, and relative momentum to clarify how each might fit within a diversified portfolio.
PSA Overview and Recent Performance
Public Storage is the largest owner-operator of self-storage facilities in the United States and a member of the S&P 500. Its business model relies on month-to-month leases, low recurring capital needs, and a well-known brand, which together support steady funds from operations (FFO), the preferred earnings metric for REITs. In recent weeks, PSA has commanded attention for its external growth strategy. The company completed its roughly $10.5 billion all-stock acquisition of National Storage Affiliates, integrating more than 1,000 properties, and separately announced a $1.2 billion acquisition of Public Storage Canada spanning 68 properties.
Fundamentally, the company reported core FFO of $4.17 per share for its most recent quarter and raised its full-year core FFO guidance to a midpoint near $16.90, reflecting improving move-in rents and occupancy. Same-store revenue and net operating income (NOI) remained slightly negative, pressured by new supply in certain Sun Belt markets, but management has guided toward a return to positive same-store growth late in the year. The stock has rallied roughly 19.5% over the trailing three months, supported by its A2/A credit ratings and a quarterly dividend near $3 per share.
SMA Overview and Recent Performance
Symmetry Medical Inc. is a specialized medical device company operating through two segments: Original Equipment Manufacturer (OEM) Solutions, which supplies surgical instruments, orthopedic implants, and sterilization cases and trays to device makers, and Symmetry Surgical, which sells reusable and sterile disposable surgical instruments to hospitals and ambulatory centers. Its revenue is therefore closely linked to procedure volumes and supply-chain activity across the broader healthcare equipment industry.
In recent market activity, SMA has traded within a comparatively narrow band near its 52-week high, reflecting a period of consolidation rather than a decisive breakout. The company demonstrates a strong operating margin in the high-20% range and an attractive trailing dividend yield, yet its smaller equity base and lower trading liquidity amplify day-to-day volatility relative to large caps. Quarterly results have shown modest earnings contributions, with the business remaining sensitive to elective-procedure demand and capital equipment purchasing cycles. Unlike PSA, SMA does not command a diversified, defensive asset base, and its performance is more tied to industry-specific spending trends.
Trending AI Robots
Tickeron maintains a large library of AI Trading Bots covering thousands of different tickers, each built around distinct trading styles, strategies, timeframes, performance metrics, and watchlists. Because market conditions shift constantly, not every bot is equally suitable at a given moment. The Trending AI Robots section addresses this by curating only the strategies currently demonstrating the strongest alignment with prevailing market dynamics. This focused selection helps traders filter a broad universe down to a smaller set of timely, actionable models rather than manually screening hundreds of bots. Whether your focus is momentum, mean reversion, or multi-ticker rotation, the curated list offers a starting point for evaluating automated approaches across both PSA and SMA and beyond.
Head-to-Head Comparison
The two companies diverge on nearly every structural dimension. PSA is a defensive, asset-heavy REIT generating predictable rental cash flows, with growth driven by acquisitions, development, and ancillary services such as tenant insurance. SMA is an asset-light manufacturer and distributor of surgical products, with growth tied to procedure volumes, hospital budgets, and OEM partnerships. In terms of market capitalization and liquidity, PSA dwarfs SMA, which translates into materially different volatility and institutional participation.
On momentum, PSA has demonstrated clearer directional strength, aided by catalysts such as the NSA integration and raised guidance, even as new storage supply tempers same-store growth. SMA has been more range-bound, with stable fundamentals but fewer near-term catalysts to drive a re-rating. Risk profiles also contrast: PSA faces exposure to interest rates and regional supply imbalances, while SMA faces concentration risk in a narrower product set and dependence on healthcare capital spending. Dividend investors will note both pay dividends, though PSA's payout is backed by a far larger, more diversified cash-flow base.
Tickeron AI Verdict
Based on observable factors, Tickeron's AI would likely favor Public Storage over Symmetry Medical in the current environment. PSA combines a consistent, institutionally supported uptrend, an investment-grade balance sheet, and clear catalysts in the form of completed acquisitions and upwardly revised guidance. Its relative stability and income characteristics give trend-following models a more reliable signal set. SMA's strong margins and yield are noteworthy, but its smaller size, thinner liquidity, and range-bound behavior currently provide less confirmation of sustained trend strength. This assessment is probabilistic rather than definitive and reflects relative positioning, not a guarantee of future returns.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSA is a Hold and SMA is a Hold.
PSA in upward trend: 10-day moving average moved above 50-day moving average on October 26, 2026
The 10-day moving average for PSA crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 58%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on PSA as a result. In 52 of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 51%.
The Moving Average Convergence Divergence (MACD) for PSA just turned positive on October 06, 2026. Looking at past instances where PSA's MACD turned positive, the stock continued to rise in 24 of 44 cases over the following month. The odds of a continued upward trend are 55%.
PSA moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where PSA advanced for three days, in 181 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 85 of 237 cases where PSA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 36%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 18 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PSA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
PSA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 21 (best 1 - 100 worst), indicating outstanding price growth. PSA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 27 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 28 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 59 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PSA's P/B Ratio (13.027) is very high in comparison to the industry average of (2.701). P/E Ratio (32.078) is within average values for comparable stocks, (18.006). Projected Growth (PEG Ratio) (3.813) is also within normal values, averaging (11.190). Dividend Yield (0.036) settles around the average of (0.049) among similar stocks. P/S Ratio (10.616) is also within normal values, averaging (8.208).
SMA in upward trend: 10-day moving average crossed above 50-day moving average on October 15, 2026
The 10-day moving average for SMA crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on SMA as a result. In 19 of 29 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
SMA moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where SMA advanced for three days, in 61 of 105 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
The Aroon Indicator entered an Uptrend today. In 37 of 57 cases where SMA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.
Bearish Trend Analysis
The 10-day RSI Indicator for SMA moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 8 similar instances where the indicator moved out of overbought territory. In 5 of the 8 cases, the stock moved lower in the following days. This puts the odds of a move lower at 62%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 17 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
SMA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. SMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.863) is normal, around the industry mean (2.701). SMA has a moderately high P/E Ratio (64.867) as compared to the industry average of (18.006). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.190). SMA has a moderately low Dividend Yield (0.014) as compared to the industry average of (0.049). P/S Ratio (5.828) is also within normal values, averaging (8.208).
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SMA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
PSA | ||
|---|---|---|
OUTLOOK RATING 1..100 | 35 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 59 | |
SMR RATING 1..100 | 27 | |
PRICE GROWTH RATING 1..100 | 21 | |
P/E GROWTH RATING 1..100 | 28 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| PSA | SMA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 65% | 2 days ago 63% |
| Stochastic ODDS (%) | 2 days ago 59% | 2 days ago 52% |
| Momentum ODDS (%) | 3 days ago 51% | 7 days ago 66% |
| MACD ODDS (%) | 7 days ago 55% | N/A |
| TrendWeek ODDS (%) | 2 days ago 57% | 2 days ago 61% |
| TrendMonth ODDS (%) | 2 days ago 50% | 2 days ago 58% |
| Advances ODDS (%) | 8 days ago 56% | 3 days ago 58% |
| Declines ODDS (%) | 6 days ago 57% | N/A |
| BollingerBands ODDS (%) | 2 days ago 56% | 2 days ago 50% |
| Aroon ODDS (%) | 2 days ago 36% | 2 days ago 65% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PSA’s FA Score shows that 3 FA rating(s) are green while SMA’s FA Score has 0 green FA rating(s).
- PSA’s FA Score: 3 green, 2 red.
- SMA’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PSA’s TA Score shows that 6 TA indicator(s) are bullish while SMA’s TA Score has 5 bullish TA indicator(s).
- PSA’s TA Score: 6 bullish, 4 bearish.
- SMA’s TA Score: 5 bullish, 3 bearish.
Price Growth
PSA (@Miscellaneous Manufacturing) experienced а +0.76% price change this week, while SMA (@Miscellaneous Manufacturing) price change was +5.40% for the same time period.
The average weekly price growth across all stocks in the @Miscellaneous Manufacturing industry was -1.29%. For the same industry, the average monthly price growth was +5.66%, and the average quarterly price growth was +7.88%.
Reported Earning Dates
PSA is expected to report earnings on Feb 23, 2027.
Industries' Descriptions
@Miscellaneous Manufacturing (-1.29% weekly)Miscellaneous manufacturing refers to a diverse range of products that cannot readily be categorized into other specific sectors of manufacturing. Major U.S. players in this industry include AMETEK, Inc.( analytical instruments, precision components and specialty materials), Dover Corporation (solutions for efficiency and safety of extracting oil and gas, e.g. rod lifts, progressing cavity pumps, gas lifts etc.; solutions for the transportation/transformation of solid waste; products for safe handling of critical fluids for various industries; systems for commercial-refrigeration, heating and cooling, and food and beverage packaging), and Carlisle Companies Incorporated (niche markets including commercial roofing, energy, lawn and garden, mining and construction equipment, aerospace and electronics, dining and food delivery, and healthcare), among others.
Advertisement
PSA and
Correlation & Price change
A.I.dvisor indicates that over the last year, PSA has been closely correlated with EXR. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if PSA jumps, then EXR could also see price increases.
SMA and
Correlation & Price change
A.I.dvisor indicates that over the last year, SMA has been closely correlated with CUBE. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMA jumps, then CUBE could also see price increases.
| Ticker / NAME | Correlation To SMA | 1D Price Change % | ||
|---|---|---|---|---|
| SMA | 100% | -2.67% | ||
| CUBE - SMA | 72% Closely correlated | +0.04% | ||
| EXR - SMA | 71% Closely correlated | -0.76% | ||
| PSA - SMA | 71% Closely correlated | -0.66% | ||
| REXR - SMA | 48% Loosely correlated | -1.94% | ||
| STAG - SMA | 48% Loosely correlated | -0.19% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XHOA | 25.22 | N/A | N/A |
| Corgi U.S. Real Estate 2x Daily ETF (XHOA) | |||
| AQLG | 25.15 | N/A | N/A |
| HCM Large Cap Growth ETF | |||
| MBSF | 25.58 | -0.02 | -0.08% |
| Regan Floating Rate MBS ETF (MBSF) | |||
| BUFC | 43.15 | -0.07 | -0.16% |
| AB Conservative Buffer ETF (BUFC) | |||
| UGLD | 18.27 | -1.11 | -5.73% |
| Direxion Daily Gold Bull 2X ETF (UGLD) | |||